Hennion & Walsh Asset Management Inc. Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hennion & Walsh Asset Management Inc. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,237 shares of the medical equipment provider's stock after buying an additional 907 shares during the period. Hennion & Walsh Asset Management Inc.'s holdings in Intuitive Surgical were worth $6,909,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Financial Enhancement Group LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $884,000. RMR Wealth Builders raised its stake in shares of Intuitive Surgical by 4.3% in the fourth quarter. RMR Wealth Builders now owns 5,699 shares of the medical equipment provider's stock valued at $2,975,000 after acquiring an additional 236 shares during the period. Outlook Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 7.1% in the fourth quarter. Outlook Wealth Advisors LLC now owns 437 shares of the medical equipment provider's stock valued at $228,000 after acquiring an additional 29 shares during the period. Essex Savings Bank lifted its holdings in shares of Intuitive Surgical by 22.9% in the 4th quarter. Essex Savings Bank now owns 660 shares of the medical equipment provider's stock worth $344,000 after acquiring an additional 123 shares during the last quarter. Finally, Wolff Wiese Magana LLC grew its holdings in Intuitive Surgical by 4.3% during the 4th quarter. Wolff Wiese Magana LLC now owns 1,194 shares of the medical equipment provider's stock valued at $623,000 after purchasing an additional 49 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the business's stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares in the company, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.80% of the company's stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $3.97 during trading hours on Thursday, reaching $584.08. The stock had a trading volume of 2,119,290 shares, compared to its average volume of 1,655,838. The company has a market cap of $208.04 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 4.66 and a beta of 1.39. The business's 50 day moving average price is $538.34 and its 200-day moving average price is $497.08. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $585.50.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have issued reports on ISRG. Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a report on Friday, October 18th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Finally, Raymond James upped their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.